The article describes Phivida CBD products as providing all of the benefits, with none of the side effects. “Its products get people healthy, not high. CBD is a non-psychoactive component of hemp, and unlike THC from marijuana, shows no indications for addiction.”, The article states.
The article estimates the cannabidiol (CBD) market to grow 700% by 2020. It also mentions a report by Hemp Business Journal which projects he CBD market to grow to $2.1 billion by 2020.
According to the article three incidents were major catalysts in boosting the launch of of the company on the Canadian Securities Exchange. They were as follows:
- World Anti-Doping removed cannabbidol (CBD) from its prohibited substance list
- A World Health Organization (WHO) report found no adverse health outcomes for CBD
- Cannabinoid infused edibles (food and beverage) were legalized just two days before Phivida’s initial public offering was launched
Click here to read the complete article